GemPharmatech Co., Ltd. (SHA:688046)

China · Delayed Price · Currency is CNY

37.94

+2.96 (8.46%)

At close: Sep 30, 2026

Market Cap	15.52B +114.9%
Revenue (ttm)	878.13M +21.7%
Net Income	182.55M +74.9%
EPS	0.45 +79.3%
Shares Out	409.16M
PE Ratio	84.01
Forward PE	77.43
Dividend	0.22 (0.58%)
Ex-Dividend Date	Jun 9, 2026

Volume	16,589,266
Open	34.86
Previous Close	34.98
Day's Range	34.83 - 38.78
52-Week Range	12.89 - 43.47
Beta	0.90
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breed... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2017

Employees 1,692

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688046

Full Company Profile

Financial Performance

In 2025, GemPharmatech's revenue was 793.39 million, an increase of 15.51% compared to the previous year's 686.84 million. Earnings were 142.64 million, an increase of 29.88%.

Financial Statements